Inactive Instrument
GW PHARMACEUTICALS Stock OTC Markets
Stocks
GWPRF
GB0030544687
Biotechnology & Medical Research
OTC Markets Traded
| 1 day | +16.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Alkesh Patel
SEC | Corporate Secretary | - | 2024-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amanda Flanagan
BRD | Director/Board Member | 55 | 2025-02-09 |
David Spackman
BRD | Director/Board Member | 50 | 2023-01-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.92% | +17.65% | - | - | 6.91B | |
| -2.23% | -0.03% | +61.34% | +109.10% | 56.24B | |
| +4.60% | +5.85% | +54.47% | +43.04% | 43.76B | |
| -1.44% | +5.50% | -13.41% | -19.24% | 23.32B | |
| -2.69% | +4.27% | -4.47% | +379.00% | 21.34B | |
| +3.22% | +3.77% | +19.92% | -35.05% | 15.75B | |
| -0.67% | +1.18% | +12.91% | -39.22% | 15.6B | |
| -1.01% | -1.27% | +25.52% | +171.92% | 13.18B | |
| +3.07% | +3.59% | +25.54% | - | 12.01B | |
| +4.95% | +7.51% | +123.21% | +249.05% | 11.87B | |
| Average | +2.47% | +3.76% | +33.89% | +107.33% | 23.68B | |
| Weighted average by Cap. | +1.02% | +3.54% | +37.76% | +98.07% |
Employees
1,161
